MSLN and congenital rubella syndrome: There are a few reports on the incidence of compartmental CRS in a patient with recurrent ovarian cancer after treatment with anti-mesothelin CAR T cell (98) or the occurrence of severe CRS in a 45-year-old patient with malignant mesothelioma after the treatment with anti-EpCAM CAR T cells (87).